ArticleFrontiers in medicine2020

Validation of Early Increase in Complement Activation Marker sC5b-9 as a Predictive Biomarker for the Development of Thrombotic Microangiopathy After Stem Cell Transplantation.

Blanka Mezö et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.